Century Therapeutics, Inc. (IPSC) Misses Q2 EPS by 6c
Tweet
Share
E-mailGet Alerts IPSC Hot Sheet
Join SI Premium – FREE
Century Therapeutics, Inc. (NASDAQ: IPSC) reported Q2 EPS of ($0.17), $0.06 worse than the analyst estimate of ($0.11).
For earnings history and earnings-related data on Century Therapeutics, Inc. (IPSC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- North American Construction (NOA) Tops Q2 EPS by 9c; Offers Guidance
- Park Dental Partners, Inc. (PARK) Tops Q2 EPS by 28c
- ArriVent BioPharma, Inc. (AVBP) Misses Q2 EPS by 13c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
